14 October 2010

An important landmark has been achieved with the addition of a general statement indicating interchangeability pertinent to Health Canada in all Q4B topic-specific annexes.

This adds to the declaration made by the regulators in EU, Japan and US that any of the texts in their pharmacopoeia can be used as interchangeable in these three ICH regions. This is an important way of reducing testing requirements for industry.